Related Experiment Video
Updated: Jul 25, 2026

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy
Published on: November 3, 2016
Factors affecting cognitive, motor, behavioral and executive functioning in children with phenylketonuria
G L Arnold1, B M Kramer, R S Kirby
1Department of Pediatrics, University of Rochester School of Medicine and Dentistry, NY 14642, USA.
Maintaining low phenylalanine levels is crucial for children with phenylketonuria (PKU). Lower levels correlate with better cognitive function and temperament, while fluctuations may impact executive function.
Area of Science:
- Neuroscience
- Metabolic Disorders
- Pediatric Health
Background:
- Classical phenylketonuria (PKU) is a metabolic disorder requiring lifelong management.
- Elevated phenylalanine levels can negatively impact neurodevelopment.
Purpose of the Study:
- To investigate the relationship between phenylalanine levels and cognitive, executive, behavioral, and motor functions in children with PKU.
- To explore the impact of age, phenylalanine level variation, and average levels on neurodevelopmental outcomes.
Main Methods:
- Cognitive, executive, behavioral, and motor assessments were administered to 18 children with PKU (aged 12-101 months).
- Analysis included current and lifetime average phenylalanine levels, and individual variation (standard deviation).
Main Results:
- Lower phenylalanine levels correlated with higher cognitive function in children aged 3+ years.
- Elevated phenylalanine levels were associated with more difficult temperament.
- Motor function was impaired, particularly at levels >360 micromol/l.
- Increased phenylalanine level variation correlated with poorer executive function.
Conclusions:
- Maintaining phenylalanine levels below 360 micromol/l may be essential for optimal cognitive and behavioral outcomes in PKU.
- Phenylalanine level fluctuations represent a potential concern for executive function and warrant further investigation.
More Related Videos
11:01Quantitative Autoradiographic Method for Determination of Regional Rates of Cerebral Protein Synthesis In Vivo
Published on: June 28, 2019
10:02Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Published on: March 12, 2020
Related Concept Videos
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Inborn Errors of Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Information Processing Approach
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.